News: ANP Antisense Therapeutics Submits Clinical Trial Application For Atl1102 Phase Iib Dmd Trial..., page-15

IME the more quiet a company and the less time they spend on marketing and pumping, the more they know their product is the real deal.
Have been in biotech for years and without fail, the ones that ann every little thing into a pump are the ones that have an empty hand of cards.
The ones that stay silent but have trials showing positive results for people who dig deeper are the winners.

The cannabis space would not stop with ann, or look at IMU or MSB.....

Compare that to NEU who barely have announcements sometime spanning a year of no announcements.

ANP has NEU written all over it